Figure 94-1 Recommended immunization schedules for persons ages 0 through 18 years—United States, 2013. (Approved by the Advisory Committee on Immunization Practices; American Academy of Pediatrics; American Academy of Family Physicians; and American College of Obstetricians and Gynecologists). (Courtesy of the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, http://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html
For further guidance on the use of the vaccines mentioned below, see: http://www.cdc.gov/vaccines/pubs/acip-list.htm.
1. Hepatitis B (HepB) vaccine. (Minimum age: birth) Routine vaccination: At birth  Administer monovalent HepB vaccine to all newborns before hospital  discharge.  For infants born to hepatitis B surface antigen (HBsAg)–positive mothers,  administer HepB vaccine and 0.5 mL of hepatitis B immune globulin  (HBIG) within 12 hours of birth. These infants should be tested for HBsAg and antibody to HBsAg (anti-HBs) 1 to 2 months after completion of the  HepB series, at age 9 through 18 months (preferably at the next well-child visit).  If mother’s HBsAg status is unknown, within 12 hours of birth administer  HepB vaccine to all infants regardless of birth weight. For infants  weighing <2,000 grams, administer HBIG in addition to HepB within 12  hours of birth. Determine mother’s HBsAg status as soon as possible  and, if she is HBsAg-positive, also administer HBIG for infants weighing 2,000 grams (no later than age 1 week). Doses following the birth dose  The second dose should be administered at age 1 or 2 months.  Monovalent HepB vaccine should be used for doses administered before  age 6 weeks.  Infants who did not receive a birth dose should receive 3 doses of a  HepB-containing vaccine on a schedule of 0, 1 to 2 months, and 6  months starting as soon as feasible. See Figure 2.  The minimum interval between dose 1 and dose 2 is 4 weeks and  between dose 2 and 3 is 8 weeks. The final (third or fourth) dose in the  HepB vaccine series should be administered no earlier than age 24  weeks, and at least 16 weeks after the first dose.  Administration of a total of 4 doses of HepB vaccine is recommended  when a combination vaccine containing HepB is administered after the  birth dose. Catch-up vaccination:  Unvaccinated persons should complete a 3-dose series.  A 2-dose series (doses separated by at least 4 months) of adult formulation Recombivax HB is licensed for use in children aged 11  through 15 years.  For other catch-up issues, see Figure 2.
2. Rotavirus (RV) vaccines. (Minimum age: 6 weeks for both RV-1 [Rotarix] and RV-5 [RotaTeq]). Routine vaccination:  Administer a series of RV vaccine to all infants as follows: 1.
If RV-1 is used, administer a 2-dose series at 2 and 4 months of age.
2.
If RV-5 is used, administer a 3-dose series at ages 2, 4, and 6 months.
3.
If any dose in series was RV-5 or vaccine product is unknown for any      dose in the series, a total of 3 doses of RV vaccine should be administered.